
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.23 | 2.23 | 0.00 |
Stocks | 97.77 | 97.77 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.88 | 19.45 |
Price to Book | 4.23 | 4.49 |
Price to Sales | 1.57 | 2.56 |
Price to Cash Flow | 17.03 | 17.33 |
Dividend Yield | 1.51 | 1.10 |
5 Years Earnings Growth | 10.36 | 12.17 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.78 | 99.66 |
Consumer Defensive | 0.11 | 0.43 |
Financial Services | 0.05 | 0.49 |
Industrials | 0.05 | 0.05 |
Technology | 0.01 | 0.17 |
Number of long holdings: 418
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.54 | 813.48 | +1.48% | |
UnitedHealth | US91324P1021 | 8.06 | 488.65 | +1.48% | |
AbbVie | US00287Y1091 | 4.72 | 211.77 | +0.10% | |
J&J | US4781601046 | 4.40 | 162.81 | -0.11% | |
Merck&Co | US58933Y1055 | 3.84 | 94.57 | -0.15% | |
Thermo Fisher Scientific | US8835561023 | 3.67 | 522.05 | +2.58% | |
Abbott Labs | US0028241000 | 3.58 | 126.71 | -2.45% | |
Intuitive Surgical | US46120E6023 | 3.27 | 484.44 | +1.61% | |
Amgen | US0311621009 | 2.47 | 313.71 | +0.34% | |
Boston Scientific | US1011371077 | 2.43 | 97.16 | +1.88% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 730.53B | 1.13 | 11.51 | - | ||
Vanguard 500 Index Admiral | 568.34B | 1.44 | 12.50 | 12.94 | ||
Vanguard Total Stock Market Admiral | 407.95B | 1.12 | 11.49 | 12.30 | ||
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard 500 Index Institutional Se | 207.17B | 1.44 | 12.54 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review